CardioExchange is pleased to reprint selections from Dr. Richard Lehman’s weekly journal review blog at BMJ.com. Selected summaries are relevant to our audience, but we encourage members to engage with the entire blog.
NEJM 17 Jan 2013 Vol 368
A Review of Drug-Eluting Stents (pg. 254): It’s time to stop watching the snow falling by the lamp-posts, close the curtains, poke the fire and get out some old DVDs. Now what have we here? The Star Wars trilogy, Lord of the Rings, Agatha Christie’s Poirot: the Complete Collection—and oh look, Drug Eluting Stents from NEJM studios. Starring Giulio Stefanini as Sirolimus and David Holmes as Paclitaxel. How about it, folks? Nah—let’s have Game of Thrones. We prefer bare metal.
Lancet 19 Jan 2013 Vol 381
Hypertrophic Cardiomyopathy (pg. 242): Many Lancet seminars get bogged down in endless genomic detail and speculation, but because most hypertrophic cardiomyopathy has now been shown to be due to mutations of just 11 genes, the authors can concentrate on clinical issues, which they do very well. “After more than 50 years, hypertrophic cardiomyopathy has been transformed from a rare and largely untreatable disorder to a common genetic disease with management strategies that permit realistic aspirations for restored quality of life and advanced longevity.”